Table 1.
PSMA ligands used in patients - status October 2017
| COMPOUND | RADIONUCLIDE | REFERENCE |
|---|---|---|
| “DUPA”-based | ||
| PSMA-11 (PSMA HBED-CC) | 68Ga | Eder et al. [3] Afshar-Oromieh et al. [4] |
| PSMA-617 | 177Lu, 225Ac, 64Cu (68Ga, 111In) | Afshar-Oromieh et al. [22] Benesova et al. [23] |
| PSMA-I&T | 68Ga, 177Lu, 111In | Weineisen et al. [24] |
| PSMA-I&S | 99mTc | Robu et al. [25] |
| MIP-1404/1405/1427 | 99mTc | Hillier et al. [26] |
| MIP-1095 | 131I (124I) | Barret et al. [27] |
| DCFBC | 18F | Cho et al. [28] |
| DCFPyL | 18F | Chen et al. [29] |
| PSMA-1007 | 18F | Cardinale et al. [30] Giesel et al. [31] |
| Antigen-targeted | ||
| Capromab pendetide (ProstaScint®) | 111In | Manyak [32] |
| J591 | 111In, 90Y, 177Lu, 89Zr | Bander et al. [2] |
| IAB2M | 89Zr | Pandit-Taskar et al. [33] |